Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Bioscience entities : Enochian biosciences, inc. save search
Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans
Published: 2022-03-15 (Crawled : 12:30) - enochianbio.com
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: -1.39%
H: 5.89%
C: 2.82%
partnership car-t potential bioscience hiv a3ar
Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors
Published: 2021-12-03 (Crawled : 12:00) - globenewswire.com
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
solid tumors conference presentation potential bioscience vaccine
Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference
Published: 2021-09-13 (Crawled : 12:00) - globenewswire.com
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: 0.51%
H: 1.14%
C: -4.42%
conference bioscience
Distinguished Scientific and Clinical Leader to Join Enochian BioSciences’ Hepatitis B Cure Scientific Advisory Board
Published: 2021-08-23 (Crawled : 13:00) - enochianbio.com
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: 3.0%
H: 8.73%
C: 4.79%
hepatitis bioscience
Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer
Published: 2021-07-20 (Crawled : 12:00) - biospace.com/
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: -1.26%
H: 3.34%
C: 0.85%
bioscience
Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity
Published: 2021-06-30 (Crawled : 12:00) - biospace.com/
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: 0.78%
H: 1.17%
C: -3.31%
presentation bioscience
Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: 2021-06-14 (Crawled : 19:00) - globenewswire.com
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: 5.74%
H: 1.95%
C: -17.27%
offering bioscience nasdaq
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
Published: 2021-06-14 (Crawled : 12:00) - biospace.com/
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: 169.39%
H: 9.34%
C: -42.85%
fda fda acceptance potential hiv bioscience
Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference
Published: 2021-02-22 (Crawled : 23:00) - globenewswire.com
ENOB 4 | $0.7 0.0% 88K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.63%
life science bioscience
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.